CN100500169C - 一种治疗心血管疾病的超微粉中药制剂及其制备方法 - Google Patents
一种治疗心血管疾病的超微粉中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN100500169C CN100500169C CNB2006100165902A CN200610016590A CN100500169C CN 100500169 C CN100500169 C CN 100500169C CN B2006100165902 A CNB2006100165902 A CN B2006100165902A CN 200610016590 A CN200610016590 A CN 200610016590A CN 100500169 C CN100500169 C CN 100500169C
- Authority
- CN
- China
- Prior art keywords
- preparation
- make
- parts
- chinese medicine
- superfine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 37
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 208000024172 Cardiovascular disease Diseases 0.000 title claims description 6
- 239000004863 Frankincense Substances 0.000 claims abstract description 19
- 239000006187 pill Substances 0.000 claims abstract description 13
- 239000008187 granular material Substances 0.000 claims abstract description 5
- 239000007902 hard capsule Substances 0.000 claims abstract description 4
- 239000007901 soft capsule Substances 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims abstract 2
- 241000717739 Boswellia sacra Species 0.000 claims description 18
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims description 18
- 241000736148 Styrax Species 0.000 claims description 18
- 239000004870 Styrax Substances 0.000 claims description 18
- 235000000126 Styrax benzoin Nutrition 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 11
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 241000132446 Inula Species 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- 244000303379 Styrax officinalis Species 0.000 abstract 1
- 235000001361 Styrax officinalis Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000019382 gum benzoic Nutrition 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 210000002421 cell wall Anatomy 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000007931 coated granule Substances 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- -1 or the bag film-coat Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100165902A CN100500169C (zh) | 2006-02-21 | 2006-02-21 | 一种治疗心血管疾病的超微粉中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100165902A CN100500169C (zh) | 2006-02-21 | 2006-02-21 | 一种治疗心血管疾病的超微粉中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1846722A CN1846722A (zh) | 2006-10-18 |
CN100500169C true CN100500169C (zh) | 2009-06-17 |
Family
ID=37076603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100165902A Active CN100500169C (zh) | 2006-02-21 | 2006-02-21 | 一种治疗心血管疾病的超微粉中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100500169C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104367908B (zh) * | 2013-08-12 | 2017-09-15 | 成都百草和济科技有限公司 | 一种治疗心血管疾病的药物组合物及其制备方法和用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1541770A (zh) * | 2003-07-10 | 2004-11-03 | 中山大学 | 中药材的低温超微粉碎方法 |
-
2006
- 2006-02-21 CN CNB2006100165902A patent/CN100500169C/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1541770A (zh) * | 2003-07-10 | 2004-11-03 | 中山大学 | 中药材的低温超微粉碎方法 |
Non-Patent Citations (4)
Title |
---|
中华人民共和国卫生部 药品标准 中药成方制剂. 中华人民共和国卫生部药典委员会,158,中华人民共和国卫生部药典委员会. 1998 |
中华人民共和国卫生部 药品标准 中药成方制剂. 中华人民共和国卫生部药典委员会,158,中华人民共和国卫生部药典委员会. 1998 * |
超微粉碎技术在中药生产中的应用. 宁宏双,郝爱民.天津药学,第17卷第5期. 2005 |
超微粉碎技术在中药生产中的应用. 宁宏双,郝爱民.天津药学,第17卷第5期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN1846722A (zh) | 2006-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101579364A (zh) | 一种药物组合物及其制备方法 | |
DE202016008638U1 (de) | Medizinische Vorrichtung zur Behandlung von HPV-Hautinfektionen | |
CN1994332A (zh) | 一种中药材的粉碎方法 | |
CN101991689B (zh) | 一种治疗瘙痒性皮肤病的药物组合物 | |
CN100500169C (zh) | 一种治疗心血管疾病的超微粉中药制剂及其制备方法 | |
CN101108872A (zh) | 植物生物碱提取物及其制剂与用途 | |
CN100434065C (zh) | 一种妇科止血制剂 | |
CN1762347A (zh) | 穿心莲内酯制剂及其制备方法 | |
CN110585117A (zh) | 一种根皮素的温敏性凝胶制剂及其制备方法和应用 | |
CN100443098C (zh) | 一种治疗妇科疾病的药物 | |
CN102552820A (zh) | 一种制备降脂通络软胶囊的方法 | |
WO2023052393A1 (de) | Mechanochemisch vorbehandelte, schwermetallfreie aktivkohlepartikel a, topische arzneimittel, medizinprodukte und kosmetika, herstellverfahren und verwendungen | |
CN106236650B (zh) | 一种祛痘控油乳膏剂及其制备方法 | |
CN100500179C (zh) | 一种治疗风湿病的超微粉中药制剂及其制备方法 | |
CN100531755C (zh) | 一种治疗风湿病的超微粉中药制剂的制备方法 | |
US20050084549A1 (en) | Fiber rich fraction of Trigonella Foenum-graceum seeds and its use as a pharmaceutical excipient | |
CN1994330B (zh) | 一种动物类中药材的粉碎方法 | |
CN101468059A (zh) | 治疗近视的凝胶贴剂及其制备方法 | |
CN100551360C (zh) | 板蓝根泡腾片及其制备方法 | |
CN102552595A (zh) | 一种四七汤整合型新剂型制备技术及其生产方法 | |
CN109999111A (zh) | 一种治疗痤疮的药物组合物及其制备方法 | |
CN1939375A (zh) | 一种治疗心血管疾病的超微粉中药制剂的制备方法 | |
CN103028095A (zh) | 一种姜附汤整合型新剂型制备技术及其生产方法 | |
CN101219126A (zh) | 一种β-胡萝卜素微丸及其制备方法 | |
CN1762475A (zh) | 感冒清热泡腾片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Tongyao Pharmaceutical Group Corporation Assignor: Xiu Laigui Contract fulfillment period: 2009.4.20 to 2019.4.20 Contract record no.: 2009220000016 Denomination of invention: Superfine Chinese medicine powder prepn for treating cardiovascular diseases and its prepn process Granted publication date: 20090617 License type: Exclusive license Record date: 20090615 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.4.20 TO 2019.4.20; CHANGE OF CONTRACT Name of requester: TONGYAO PHARMACEUTICAL GROUP CO., LTD. Effective date: 20090615 |
|
ASS | Succession or assignment of patent right |
Owner name: XIUZHENG PHARMACEUTICAL GROUP HOIDING CO., LTD. Effective date: 20131023 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20131023 Address after: 130012 Jilin correction pharmaceutical industry, No. 2426 Qianjin Street, Changchun hi tech Development Zone, Jilin Patentee after: Xiu Laigui Patentee after: Xiuzheng Pharmaceutical Group HoIding Co., Ltd. Address before: 130012 Jilin correction pharmaceutical industry, No. 2426 Qianjin Street, Changchun hi tech Development Zone, Jilin Patentee before: Xiu Laigui |
|
ASS | Succession or assignment of patent right |
Owner name: XIUZHENG PHARMACEUTICAL GROUP HOIDING CO., LTD. Free format text: FORMER OWNER: XIU LAIGUI Effective date: 20150812 Free format text: FORMER OWNER: XIUZHENG PHARMACEUTICAL GROUP HOIDING CO., LTD. Effective date: 20150812 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150812 Address after: 134000 amendment Road 36, Jilin, Tonghua Patentee after: Xiuzheng Pharmaceutical Group HoIding Co., Ltd. Address before: 130012 Jilin correction pharmaceutical industry, No. 2426 Qianjin Street, Changchun hi tech Development Zone, Jilin Patentee before: Xiu Laigui Patentee before: Xiuzheng Pharmaceutical Group HoIding Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to an ultra-fine powder traditional Chinese medicine preparation for treating cardiovascular diseases and a preparation method thereof Effective date of registration: 20211223 Granted publication date: 20090617 Pledgee: Tonghua Xinhua sub branch of Bank of Jilin Co.,Ltd. Pledgor: Xiuzheng Pharmaceutical Group Co.,Ltd. Registration number: Y2021220000108 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |